Sophia T Chen, MD
Ophthalmology · Oakland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Office
- 1
- Since medical school
- 28 years
- New York University School of Medicine, 1998
Offices
1 location
Hospitals listed: Alta Bates Summit Medical Center - Alta Bates Camp. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chen’s office at (510) 350-8741 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A82768 · Current
Licensed to practise in California · since 2003 · expires 2028-07-31 · New York University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- 481 ASC Project LLC dba EYE MD Laser & Surgery Center, LLCAmbulatory Surgery Center · Oakland, CA2.35% owner since 2009 · accredited by AAAHCAccreditation Renewed5 inspections, 1 with deficiencies · last 2025-09-08
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$416,352
Medicare paid this office $416,352 for 1,384 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient complete exam of visual system | 956 | $88,049 | $84 |
| Removal of cataract with insertion of prosthetic lens | 115 | $69,077 | $429 |
| Incision to improve eye fluid flow | 35 | $40,837 | $869 |
| Laser repair to improve eye fluid flow | 90 | $35,305 | $232 |
| Exam of visual field with extended testing | 641 | $32,147 | $46 |
See all 19 services
| Established patient complete exam of visual system | 956 | $88,049 | $84 |
| Removal of cataract with insertion of prosthetic lens | 115 | $69,077 | $429 |
| Incision to improve eye fluid flow | 35 | $40,837 | $869 |
| Laser repair to improve eye fluid flow | 90 | $35,305 | $232 |
| Exam of visual field with extended testing | 641 | $32,147 | $46 |
| New patient complete exam of visual system | 301 | $24,584 | $82 |
| Complex removal of cataract with insertion of prosthetic lens | 24 | $24,027 | $707 |
| Dilation of fluid outflow drainage within eye | 35 | $23,289 | $542 |
| Imaging of optic nerve | 645 | $14,329 | $20 |
| Established patient problem focused exam of visual system | 115 | $12,340 | $91 |
| Photography of the retina | 265 | $8,111 | $29 |
| Transplantation of fetal sac tissue to cornea | 12 | $7,855 | $604 |
| Ultrasound scan to determine eye length and lens power | 155 | $7,488 | $35 |
| Removal of recurring cataract in lens capsule using a laser | 20 | $6,856 | $312 |
| Ct scan of cornea | 155 | $6,035 | $28 |
| Short return visit (20+ min) | 41 | $1,143 | $27 |
| Imaging of retina | 21 | $917 | $37 |
| New patient problem focused exam of visual system | 12 | $371 | $31 |
| Exam of the internal drainage system of eye | 19 | $290 | $15 |
Procedures Medicare counted
| Cataract surgery | 282 | More than 89% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of cataract with insertion of prosthetic lens | 221 | 101 | 126 | 161 | 123 | 161 |
| Dilation of fluid outflow drainage within eye | 83 | 53 | 71 | 55 | 28 | 43 |
| Incision to improve eye fluid flow | 148 | 31 | – | 46 | 52 | 47 |
| Laser repair to improve eye fluid flow | – | – | – | – | 148 | 152 |
| Complex removal of cataract with insertion of prosthetic lens | 22 | – | 32 | 37 | 59 | 34 |
| Removal of recurring cataract in lens capsule using a laser | 29 | 19 | 29 | 30 | 37 | 22 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,384 Original Medicare patients in 2024. Average age 75 · Under 65 2% · 85 and older 10% · Women 61% · Also on Medicaid 97% · Health risk score 0.97. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Diabetes 55% · Chronic kidney disease 20% · Depression 12% · Coronary heart disease 8% · COPD 8% · Cancer 7% · Atrial fibrillation 7% · Dementia 6% · Heart failure 5% · Stroke 4%.
The office billed $1,337,906, Medicare allowed $663,810 and paid $416,352; for 4,215 services of 28 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,384 | 4,215 | 75 | 0.97 | $1,337,906 | $416,352 |
| 2023 | 1,402 | 4,252 | 75 | 0.93 | $1,421,496 | $425,029 |
| 2022 | 1,375 | 4,205 | 75 | 0.91 | $1,231,725 | $376,265 |
| 2021 | 1,116 | 3,259 | 74 | 0.94 | $975,460 | $324,508 |
| 2020 | 881 | 2,416 | 74 | 1.00 | $816,307 | $236,593 |
| 2019 | 1,374 | 4,378 | 74 | 1.01 | $1,831,371 | $504,426 |
| 2018 | 1,268 | 3,837 | 75 | 1.06 | $1,429,126 | $376,185 |
| 2017 | 1,142 | 3,652 | 74 | 1.04 | $1,306,154 | $385,834 |
| 2016 | 965 | 2,645 | 74 | 1.02 | $895,060 | $332,287 |
| 2015 | 716 | 2,144 | 74 | 1.04 | $662,018 | $257,055 |
| 2014 | 478 | 1,477 | 74 | 0.93 | $383,070 | $143,860 |
| 2013 | 555 | 1,821 | 74 | 1.02 | $578,638 | $213,837 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 17 services
| Established patient complete exam of visual system | 936 | $85,378 | $82 |
| Removal of cataract with insertion of prosthetic lens | 93 | $52,879 | $430 |
| Incision to improve eye fluid flow | 38 | $42,593 | $819 |
| Complex removal of cataract with insertion of prosthetic lens | 47 | $38,494 | $652 |
| Laser repair to improve eye fluid flow | 90 | $35,067 | $237 |
| Exam of visual field with extended testing | 638 | $31,549 | $46 |
| New patient complete exam of visual system | 369 | $30,031 | $81 |
| Short return visit (20+ min) | 170 | $16,482 | $77 |
| Extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye | 21 | $16,169 | $622 |
| Imaging of optic nerve | 643 | $14,263 | $21 |
| Removal of recurring cataract in lens capsule using a laser | 34 | $12,202 | $330 |
| Transplantation of fetal sac tissue to cornea | 16 | $10,684 | $628 |
| Dilation of fluid outflow drainage within eye | 22 | $8,552 | $305 |
| Ultrasound scan to determine eye length and lens power | 153 | $7,712 | $36 |
| Photography of the retina | 254 | $7,710 | $29 |
| Ct scan of cornea | 150 | $5,768 | $27 |
| Imaging of retina | 24 | $678 | $25 |
2022: 17 services
| Established patient complete exam of visual system | 942 | $82,343 | $76 |
| Removal of cataract with insertion of prosthetic lens | 121 | $57,660 | $358 |
| Dilation of fluid outflow drainage within eye | 39 | $39,785 | $723 |
| Incision to improve eye fluid flow | 36 | $36,787 | $800 |
| Exam of visual field with extended testing | 614 | $32,388 | $45 |
| New patient complete exam of visual system | 347 | $26,191 | $75 |
| Complex removal of cataract with insertion of prosthetic lens | 31 | $21,998 | $595 |
| Imaging of optic nerve | 618 | $14,851 | $21 |
| Transplantation of fetal sac tissue to cornea | 20 | $13,385 | $608 |
| Short return visit (20+ min) | 117 | $10,773 | $66 |
| Removal of recurring cataract in lens capsule using a laser | 26 | $8,913 | $297 |
| Photography of the retina | 229 | $7,005 | $28 |
| Ultrasound scan to determine eye length and lens power | 157 | $6,758 | $31 |
| Ct scan of cornea | 158 | $5,531 | $25 |
| Imaging of retina | 59 | $1,083 | $18 |
| New patient problem focused exam of visual system | 11 | $255 | $23 |
| Exam of the internal drainage system of eye | 11 | $56 | $5 |
2021: 16 services
| Established patient complete exam of visual system | 800 | $70,962 | $79 |
| Dilation of fluid outflow drainage within eye | 56 | $64,501 | $908 |
| Removal of cataract with insertion of prosthetic lens | 98 | $47,722 | $379 |
| Exam of visual field with extended testing | 453 | $27,718 | $51 |
| New patient complete exam of visual system | 259 | $21,458 | $83 |
| Complex removal of cataract with insertion of prosthetic lens | 25 | $20,907 | $653 |
| Imaging of optic nerve | 453 | $12,186 | $22 |
| Transplantation of fetal sac tissue to cornea | 18 | $11,546 | $641 |
| Short return visit (20+ min) | 103 | $9,948 | $73 |
| Removal of recurring cataract in lens capsule using a laser | 26 | $8,451 | $291 |
| Ct scan of cornea | 133 | $5,152 | $29 |
| Ultrasound scan to determine eye length and lens power | 90 | $4,844 | $42 |
| Imaging of retina | 123 | $4,291 | $35 |
| Measurement of corneal curvature and depth of eye | 54 | $2,321 | $36 |
| Photography of the retina | 44 | $656 | $15 |
| Return visit (30+ min) | 14 | $432 | $29 |
2020: 16 services
| Dilation of fluid outflow drainage within eye | 44 | $48,345 | $912 |
| Established patient complete exam of visual system | 542 | $44,294 | $73 |
| Removal of cataract with insertion of prosthetic lens | 79 | $39,170 | $388 |
| Exam of visual field with extended testing | 347 | $14,503 | $39 |
| Incision to improve eye fluid flow | 30 | $13,098 | $423 |
| New patient complete exam of visual system | 165 | $12,327 | $75 |
| Imaging of optic nerve | 343 | $6,245 | $17 |
| Removal of recurring cataract in lens capsule using a laser | 18 | $5,610 | $295 |
| Return visit (30+ min) | 47 | $5,552 | $101 |
| Measurement of corneal curvature and depth of eye | 91 | $5,477 | $47 |
| Photography of the retina | 133 | $4,880 | $35 |
| Telephone medical discussion with physician, 21-30 minutes | 83 | $4,181 | $50 |
| Ct scan of cornea | 91 | $3,418 | $28 |
| Established patient problem focused exam of visual system | 14 | $764 | $48 |
| Short return visit (20+ min) | 17 | $746 | $41 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 21 or more minutes | 19 | $603 | $30 |
2019: 18 services
| Removal of cataract with insertion of prosthetic lens | 165 | $93,605 | $424 |
| Established patient complete exam of visual system | 930 | $87,265 | $84 |
| Dilation of fluid outflow drainage within eye | 65 | $75,601 | $911 |
| Incision to improve eye fluid flow | 112 | $74,657 | $504 |
| Exam of visual field with extended testing | 653 | $36,104 | $49 |
| New patient complete exam of visual system | 321 | $28,324 | $88 |
| Imaging of optic nerve | 663 | $17,283 | $23 |
| Transplantation of fetal sac tissue to cornea | 26 | $17,170 | $636 |
| Photography of the retina | 291 | $14,875 | $46 |
| Complex removal of cataract with insertion of prosthetic lens | 18 | $14,777 | $672 |
| Measurement of corneal curvature and depth of eye | 187 | $11,730 | $49 |
| Removal of recurring cataract in lens capsule using a laser | 27 | $8,470 | $292 |
| Ct scan of cornea | 186 | $6,730 | $28 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 16 | $4,965 | $216 |
| Short return visit (20+ min) | 60 | $4,162 | $59 |
| Established patient problem focused exam of visual system | 24 | $2,106 | $75 |
| Imaging of retina | 12 | $567 | $40 |
| Exam of the internal drainage system of eye | 11 | $188 | $17 |
2018: 15 services
| Incision to improve eye fluid flow | 107 | $85,710 | $691 |
| Removal of cataract with insertion of prosthetic lens | 160 | $76,009 | $411 |
| Established patient complete exam of visual system | 834 | $70,442 | $78 |
| Exam of visual field with extended testing | 622 | $32,280 | $46 |
| New patient complete exam of visual system | 308 | $23,667 | $77 |
| Imaging of optic nerve | 607 | $15,255 | $22 |
| Complex removal of cataract with insertion of prosthetic lens | 17 | $14,225 | $749 |
| Photography of the retina | 241 | $13,579 | $51 |
| Measurement of corneal curvature and depth of eye | 175 | $13,128 | $58 |
| Removal or relocation of corneal conjunctiva with graft | 17 | $7,937 | $441 |
| Ct scan of cornea | 171 | $6,150 | $27 |
| Removal of recurring cataract in lens capsule using a laser | 16 | $4,798 | $300 |
| Established patient problem focused exam of visual system | 27 | $2,638 | $71 |
| Short return visit (20+ min) | 37 | $1,804 | $46 |
| Imaging of retina | 20 | $779 | $35 |
2017: 16 services
| Removal of cataract with insertion of prosthetic lens | 156 | $106,408 | $519 |
| Established patient complete exam of visual system | 737 | $56,851 | $69 |
| Internal insertion of eye fluid drainage device | 65 | $47,278 | $550 |
| Incision to improve eye fluid flow | 41 | $32,102 | $683 |
| Exam of visual field with extended testing | 538 | $29,544 | $44 |
| New patient complete exam of visual system | 313 | $22,851 | $73 |
| Complex removal of cataract with insertion of prosthetic lens | 21 | $18,021 | $721 |
| Measurement of corneal curvature and depth of eye | 198 | $15,281 | $59 |
| Imaging of optic nerve | 536 | $13,221 | $20 |
| Photography of the retina | 182 | $10,683 | $56 |
| Removal of recurring cataract in lens capsule using a laser | 23 | $6,939 | $278 |
| Ct scan of cornea | 137 | $4,832 | $28 |
| Removal or relocation of corneal conjunctiva with graft | 11 | $4,542 | $413 |
| Short return visit (20+ min) | 53 | $3,607 | $59 |
| Established patient problem focused exam of visual system | 19 | $1,528 | $69 |
| Imaging of retina | 17 | $573 | $29 |
2016: 14 services
| Removal of cataract with insertion of prosthetic lens | 142 | $109,815 | $575 |
| Internal insertion of eye fluid drainage device | 63 | $81,570 | $917 |
| Established patient complete exam of visual system | 591 | $37,562 | $58 |
| Exam of visual field with extended testing | 353 | $24,340 | $57 |
| New patient complete exam of visual system | 309 | $20,014 | $65 |
| Imaging of optic nerve | 357 | $11,806 | $28 |
| Measurement of corneal curvature and depth of eye | 139 | $11,641 | $59 |
| Removal or relocation of corneal conjunctiva with graft | 16 | $6,918 | $407 |
| Removal of recurring cataract in lens capsule using a laser | 20 | $6,708 | $279 |
| Photography of the retina | 80 | $5,138 | $63 |
| Short return visit (20+ min) | 77 | $3,333 | $41 |
| Ct scan of cornea | 69 | $1,915 | $27 |
| Established patient problem focused exam of visual system | 15 | $927 | $58 |
| Imaging of retina | 21 | $720 | $31 |
2015: 14 services
| Removal of cataract with insertion of prosthetic lens | 111 | $80,318 | $578 |
| Internal insertion of eye fluid drainage device | 33 | $35,581 | $912 |
| Established patient complete exam of visual system | 359 | $30,200 | $75 |
| New patient complete exam of visual system | 287 | $25,531 | $89 |
| Exam of visual field with extended testing | 241 | $16,737 | $60 |
| Short return visit (20+ min) | 174 | $13,611 | $59 |
| Imaging of optic nerve | 253 | $10,075 | $35 |
| Removal of recurring cataract in lens capsule using a laser | 25 | $7,792 | $278 |
| Removal or relocation of corneal conjunctiva with graft | 14 | $7,272 | $428 |
| Measurement of corneal curvature and depth of eye | 139 | $7,069 | $40 |
| Photography of the retina | 63 | $4,670 | $71 |
| Established patient problem focused exam of visual system | 26 | $1,901 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 91 | $1,672 | $15 |
| Exam of the internal drainage system of eye | 16 | $328 | $21 |
2014: 12 services
| Removal of cataract with insertion of prosthetic lens | 65 | $45,656 | $550 |
| Established patient complete exam of visual system | 262 | $19,324 | $66 |
| New patient complete exam of visual system | 126 | $9,577 | $76 |
| Exam of visual field with extended testing | 156 | $9,363 | $54 |
| Short return visit (20+ min) | 167 | $8,656 | $44 |
| Imaging of optic nerve | 148 | $4,647 | $30 |
| Removal or relocation of corneal conjunctiva | 12 | $4,209 | $324 |
| Measurement of corneal curvature and depth of eye | 59 | $4,070 | $58 |
| Microfluid analysis of tears | 92 | $4,065 | $22 |
| Photography of the retina | 60 | $4,053 | $65 |
| Established patient problem focused exam of visual system | 30 | $2,146 | $72 |
| Ultrasound scan to determine eye length and lens power | 20 | $1,501 | $68 |
2013: 14 services
| Removal of cataract with insertion of prosthetic lens | 108 | $82,159 | $551 |
| Established patient complete exam of visual system | 252 | $22,006 | $81 |
| Short return visit (20+ min) | 265 | $17,508 | $51 |
| Dilation of fluid outflow drainage within eye with insertion of device to maintain open channel | 17 | $16,993 | $894 |
| Exam of visual field with extended testing | 173 | $11,594 | $57 |
| New patient complete exam of visual system | 133 | $11,187 | $84 |
| Ultrasound scan to determine eye length and lens power | 130 | $10,783 | $63 |
| Imaging of optic nerve | 174 | $6,342 | $32 |
| Return visit (30+ min) | 82 | $3,659 | $44 |
| Photography of the retina | 50 | $3,342 | $60 |
| Established patient problem focused exam of visual system | 43 | $2,941 | $61 |
| New patient visit (45+ min) | 37 | $2,369 | $64 |
| Measurement of corneal curvature and depth of eye | 24 | $2,044 | $82 |
| Exam of the internal drainage system of eye | 11 | $206 | $19 |
Medicaid work
$108,132 in 2024
Medicaid paid $108,132 for 3,877 billed services this clinician did in 2024, up to 117 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 289 | $68,682 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 749 | $12,014 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 378 | $5,925 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 12 | $5,638 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 513 | $5,010 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 738 | $3,151 |
| Injection, adrenalin, epinephrine, 0.1 mg | 54 | $1,778 |
| Ophthalmic biometry by A-scan ultrasound echography with intraocular lens power calculation | 202 | $1,030 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 236 | $861 |
| Lidocaine injection | 90 | $773 |
| Injection, lidocaine hydrochloride, 1 mg | 29 | $627 |
| Trabeculoplasty by laser surgery | 85 | $615 |
| 2024 | 3,877 | 20 | 117 | $108,132 |
| 2023 | 3,802 | 10 | 111 | $56,903 |
| 2022 | 3,597 | 10 | 138 | $58,090 |
| 2021 | 3,308 | 12 | 99 | $24,013 |
| 2020 | 2,264 | 13 | 121 | $11,725 |
| 2019 | 5,244 | 13 | 115 | $39,874 |
| 2018 | 4,398 | 16 | 113 | $58,304 |
See the largest Medicaid services in earlier years
2023
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 232 | $35,007 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 826 | $8,908 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 451 | $5,484 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 485 | $2,314 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 817 | $1,745 |
| Ophthalmic biometry by A-scan ultrasound echography with intraocular lens power calculation | 190 | $825 |
| Trabeculoplasty by laser surgery | 139 | $771 |
| Short return visit (20+ min) | 97 | $750 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 286 | $575 |
| COMPUTERIZED CORNEAL TOPOGRAPHY UNI/BI W/I&R | 279 | $523 |
2022
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 954 | $29,719 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 510 | $14,450 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 590 | $4,118 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 169 | $3,895 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 760 | $2,415 |
| Short return visit (20+ min) | 69 | $1,070 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 153 | $939 |
| COMPUTERIZED CORNEAL TOPOGRAPHY UNI/BI W/I&R | 262 | $802 |
| Ophthalmic biometry by A-scan ultrasound echography with intraocular lens power calculation | 110 | $644 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 20 | $38 |
2021
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 900 | $10,531 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 423 | $7,956 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 546 | $1,877 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 117 | $1,018 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 707 | $974 |
| Short return visit (20+ min) | 94 | $405 |
| COMPUTERIZED CORNEAL TOPOGRAPHY UNI/BI W/I&R | 219 | $401 |
| Return visit (30+ min) | 14 | $270 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 120 | $230 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 67 | $213 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 55 | $107 |
| Ophthalmic biometry by A-scan ultrasound echography with intraocular lens power calculation | 46 | $30 |
2020
| Clinic visit/encounter, all-inclusive | 28 | $3,621 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 591 | $2,841 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 277 | $2,352 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 96 | $998 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 365 | $940 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 451 | $429 |
| Return visit (30+ min) | 39 | $299 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 96 | $99 |
| COMPUTERIZED CORNEAL TOPOGRAPHY UNI/BI W/I&R | 96 | $79 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 108 | $43 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 78 | $25 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 24 | $0 |
2019
| Unclassified drugs | 137 | $10,889 |
| Clinic visit/encounter, all-inclusive | 64 | $8,119 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 279 | $6,479 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 554 | $5,598 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 1,152 | $2,778 |
| GONIOTOMY | 119 | $2,531 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 823 | $1,402 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 1,048 | $721 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 289 | $587 |
| COMPUTERIZED CORNEAL TOPOGRAPHY UNI/BI W/I&R | 320 | $525 |
| Injection, midazolam hydrochloride, per 1 mg | 26 | $125 |
| Short return visit (20+ min) | 44 | $67 |
2018
| Unclassified drugs | 272 | $19,321 |
| Clinic visit/encounter, all-inclusive | 144 | $16,643 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 256 | $7,219 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 566 | $4,116 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 875 | $2,860 |
| GONIOTOMY | 32 | $2,114 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 13 | $1,920 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 667 | $1,629 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 817 | $833 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 247 | $658 |
| COMPUTERIZED CORNEAL TOPOGRAPHY UNI/BI W/I&R | 250 | $418 |
| DETERMINATION REFRACTIVE STATE | 30 | $219 |
Drugs they prescribed that Part D paid
$960,262
Pharmacies billed $960,262 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,756) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
1,705 generic and 2,051 brand-name prescriptions · $960,262 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xiidra | 217 | $284,201 | $1,310 |
| Lumigan | 370 | $198,812 | $537 |
| Restasis | 89 | $128,642 | $1,445 |
| Tyrvaya | 107 | $84,337 | $788 |
| Cyclosporine | 88 | $42,790 | $486 |
See all 26 drugs
| Xiidra | 217 | $284,201 | $1,310 |
| Lumigan | 370 | $198,812 | $537 |
| Restasis | 89 | $128,642 | $1,445 |
| Tyrvaya | 107 | $84,337 | $788 |
| Cyclosporine | 88 | $42,790 | $486 |
| Flurbiprofen | 303 | $27,589 | $91 |
| Cequa | 35 | $27,119 | $775 |
| Prednisolone Acetate | 339 | $17,673 | $52 |
| Latanoprost | 1,041 | $15,998 | $15 |
| Eysuvis | 32 | $15,088 | $472 |
| Rocklatan | 26 | $11,141 | $428 |
| Simbrinza | 36 | $8,687 | $241 |
| Rhopressa | 13 | $6,029 | $464 |
| Vyzulta | 13 | $5,702 | $439 |
| Pilocarpine | 129 | $5,432 | $42 |
| Ciprofloxacin | 323 | $4,841 | $15 |
| Brimonidine Tartrate-Timolol | 12 | $4,791 | $399 |
| Timolol Maleate | 167 | $3,958 | $24 |
| Brinzolamide | 16 | $3,616 | $226 |
| Combigan | 12 | $3,514 | $293 |
| Dorzolamide | 180 | $2,446 | $14 |
| Brimonidine | 75 | $2,266 | $30 |
| Betaxolol | 12 | $1,135 | $95 |
| Dorzolamide-Timolol | 27 | $435 | $16 |
| Azelastine | 14 | $146 | $10 |
| Neomycin-Polymyxin-Dexameth | 12 | $103 | $9 |
Year by year
| 2024 | 3,756 | 851 | 0% (0) | 55% | $960,262 |
| 2023 | 3,995 | 880 | 0% (0) | 58% | $1,406,793 |
| 2022 | 4,033 | 824 | 0% (0) | 60% | $1,208,252 |
| 2021 | 3,580 | 720 | 0% (0) | 68% | $1,016,023 |
| 2020 | 3,556 | 649 | 0% (0) | 64% | $1,088,852 |
| 2019 | 4,811 | 840 | 0% (0) | 68% | $1,355,228 |
| 2018 | 4,343 | 751 | None | 72% | $1,096,670 |
| 2017 | 3,796 | 705 | 0% (0) | 77% | $1,035,543 |
| 2016 | 3,279 | 596 | 0% (0) | 69% | $570,816 |
| 2015 | 2,956 | 509 | 0% (0) | 70% | $425,247 |
| 2014 | 3,031 | 470 | 0% (0) | 69% | $369,559 |
| 2013 | 3,421 | 504 | 0% (0) | 74% | $409,122 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Xiidra | 269 | $334,048 | $1,242 |
| Lumigan | 508 | $321,121 | $632 |
| Restasis | 134 | $191,139 | $1,426 |
| Tyrvaya | 120 | $138,661 | $1,156 |
| Flurbiprofen | 271 | $34,957 | $129 |
| Eysuvis | 62 | $34,840 | $562 |
| Cequa | 38 | $34,224 | $901 |
| Latanoprost | 1,043 | $28,038 | $27 |
| Cyclosporine | 39 | $23,321 | $598 |
| Rocklatan | 35 | $23,126 | $661 |
| Prednisolone Acetate | 321 | $23,016 | $72 |
| Combigan | 26 | $13,081 | $503 |
| Travoprost | 29 | $8,689 | $300 |
| Simbrinza | 27 | $7,961 | $295 |
| Azopt | 16 | $7,414 | $463 |
| Dorzolamide | 219 | $6,813 | $31 |
| Timolol Maleate | 201 | $6,448 | $32 |
| Pilocarpine | 99 | $6,354 | $64 |
| Vyzulta | 14 | $5,887 | $420 |
| Ciprofloxacin | 306 | $5,567 | $18 |
| Brimonidine | 94 | $4,998 | $53 |
| Brinzolamide | 22 | $4,922 | $224 |
| Azelastine | 16 | $359 | $22 |
2022: 30 drugs
| Restasis | 274 | $446,180 | $1,628 |
| Lumigan | 486 | $292,756 | $602 |
| Xiidra | 104 | $113,252 | $1,089 |
| Eysuvis | 79 | $41,505 | $525 |
| Cequa | 44 | $36,698 | $834 |
| Flurbiprofen | 259 | $31,855 | $123 |
| Combigan | 61 | $27,773 | $455 |
| Prednisolone Acetate | 307 | $24,253 | $79 |
| Rocklatan | 31 | $23,813 | $768 |
| Tyrvaya | 31 | $19,312 | $623 |
| Latanoprost | 967 | $18,577 | $19 |
| Azopt | 34 | $15,474 | $455 |
| Restasis Multidose | 11 | $15,207 | $1,382 |
| Travoprost | 43 | $12,852 | $299 |
| Alphagan P | 23 | $9,545 | $415 |
| Rhopressa | 20 | $8,765 | $438 |
| Pilocarpine | 123 | $8,278 | $67 |
| Brimonidine | 133 | $8,084 | $61 |
| Timolol Maleate | 226 | $7,109 | $31 |
| Simbrinza | 22 | $5,913 | $269 |
| Brinzolamide | 26 | $5,911 | $227 |
| Olopatadine | 37 | $5,210 | $141 |
| Dorzolamide | 195 | $4,744 | $24 |
| Ciprofloxacin | 304 | $3,812 | $13 |
| Azelastine | 53 | $3,253 | $61 |
| Betaxolol | 18 | $1,841 | $102 |
| Dorzolamide-Timolol | 12 | $952 | $79 |
| Ketorolac Tromethamine | 15 | $447 | $30 |
| Neomycin-Polymyxin-Dexameth | 31 | $364 | $12 |
| Cyclopentolate | 14 | $187 | $13 |
2021: 24 drugs
| Restasis | 331 | $408,610 | $1,234 |
| Lumigan | 442 | $243,065 | $550 |
| Cequa | 60 | $55,230 | $921 |
| Xiidra | 45 | $46,067 | $1,024 |
| Combigan | 85 | $38,891 | $458 |
| Azopt | 78 | $33,304 | $427 |
| Restasis Multidose | 43 | $33,139 | $771 |
| Latanoprost | 846 | $23,750 | $28 |
| Flurbiprofen | 210 | $23,305 | $111 |
| Prednisolone Acetate | 284 | $19,560 | $69 |
| Rhopressa | 24 | $14,663 | $611 |
| Alphagan P | 13 | $8,570 | $659 |
| Timolol Maleate | 206 | $8,341 | $40 |
| Pilocarpine | 104 | $6,684 | $64 |
| Travoprost | 18 | $5,950 | $331 |
| Brimonidine | 87 | $5,714 | $66 |
| Olopatadine | 58 | $5,457 | $94 |
| Dorzolamide | 159 | $4,601 | $29 |
| Simbrinza | 12 | $3,291 | $274 |
| Ciprofloxacin | 266 | $2,870 | $11 |
| Betaxolol | 26 | $2,416 | $93 |
| Azelastine | 59 | $1,943 | $33 |
| Dorzolamide-Timolol | 14 | $1,093 | $78 |
| Neomycin-Polymyxin-Dexameth | 17 | $269 | $16 |
2020: 29 drugs
| Restasis | 337 | $452,732 | $1,343 |
| Lumigan | 472 | $255,516 | $541 |
| Restasis Multidose | 95 | $64,028 | $674 |
| Azopt | 112 | $49,581 | $443 |
| Combigan | 118 | $47,982 | $407 |
| Travatan Z | 102 | $43,735 | $429 |
| Xiidra | 36 | $29,943 | $832 |
| Pazeo | 69 | $21,869 | $317 |
| Latanoprost | 783 | $19,465 | $25 |
| Durezol | 39 | $13,534 | $347 |
| Travoprost | 59 | $13,527 | $229 |
| Ilevro | 33 | $11,428 | $346 |
| Prednisolone Acetate | 145 | $7,713 | $53 |
| Alphagan P | 16 | $6,799 | $425 |
| Flurbiprofen | 88 | $6,254 | $71 |
| Timolol Maleate | 254 | $6,118 | $24 |
| Dorzolamide | 165 | $5,444 | $33 |
| Simbrinza | 20 | $4,326 | $216 |
| Pilocarpine | 63 | $4,179 | $66 |
| Brimonidine | 115 | $2,848 | $25 |
| Betaxolol | 26 | $2,634 | $101 |
| Azelastine | 67 | $2,255 | $34 |
| Moxifloxacin | 43 | $2,177 | $51 |
| Dorzolamide-Timolol | 29 | $1,695 | $58 |
| Olopatadine | 19 | $1,320 | $69 |
| Ciprofloxacin | 114 | $962 | $8 |
| Ketorolac Tromethamine | 37 | $891 | $24 |
| Neomycin-Polymyxin-Dexameth | 12 | $175 | $15 |
| Levothyroxine | 18 | $174 | $10 |
2019: 29 drugs
| Restasis | 520 | $562,121 | $1,081 |
| Lumigan | 494 | $255,246 | $517 |
| Travatan Z | 364 | $132,719 | $365 |
| Restasis Multidose | 144 | $90,469 | $628 |
| Azopt | 128 | $55,666 | $435 |
| Combigan | 137 | $53,736 | $392 |
| Durezol | 150 | $29,933 | $200 |
| Ilevro | 93 | $28,759 | $309 |
| Xiidra | 23 | $25,224 | $1,097 |
| Latanoprost | 893 | $18,104 | $20 |
| Pazeo | 72 | $14,964 | $208 |
| Prednisolone Acetate | 265 | $12,277 | $46 |
| Pilocarpine | 152 | $10,896 | $72 |
| Alphagan P | 28 | $9,785 | $349 |
| Flurbiprofen | 266 | $8,647 | $33 |
| Timolol Maleate | 261 | $7,851 | $30 |
| Simbrinza | 29 | $5,533 | $191 |
| Prolensa | 17 | $4,724 | $278 |
| Dorzolamide | 130 | $4,050 | $31 |
| Ciprofloxacin | 258 | $2,980 | $12 |
| Olopatadine | 19 | $2,273 | $120 |
| Dorzolamide-Timolol | 35 | $1,805 | $52 |
| Fluorometholone | 14 | $1,732 | $124 |
| Ofloxacin | 93 | $1,424 | $15 |
| Azelastine | 50 | $1,316 | $26 |
| Brimonidine | 60 | $1,148 | $19 |
| Betaxolol | 13 | $1,084 | $83 |
| Moxifloxacin | 17 | $698 | $41 |
| Ketorolac Tromethamine | 35 | $554 | $16 |
2018: 28 drugs
| Restasis | 276 | $267,799 | $970 |
| Restasis Multidose | 447 | $267,265 | $598 |
| Lumigan | 419 | $201,925 | $482 |
| Travatan Z | 310 | $103,124 | $333 |
| Azopt | 136 | $52,371 | $385 |
| Combigan | 122 | $37,487 | $307 |
| Xiidra | 54 | $31,895 | $591 |
| Latanoprost | 699 | $14,729 | $21 |
| Prednisolone Acetate | 322 | $14,477 | $45 |
| Pazeo | 71 | $12,970 | $183 |
| Durezol | 70 | $12,758 | $182 |
| Ilevro | 38 | $10,576 | $278 |
| Pilocarpine | 139 | $10,201 | $73 |
| Alphagan P | 23 | $8,234 | $358 |
| Timolol Maleate | 249 | $6,550 | $26 |
| Vigamox | 35 | $5,835 | $167 |
| Simbrinza | 28 | $5,831 | $208 |
| Eliquis | 11 | $4,970 | $452 |
| Ofloxacin | 139 | $1,927 | $14 |
| Flurbiprofen | 244 | $1,920 | $8 |
| Moxifloxacin | 40 | $1,869 | $47 |
| Ketorolac Tromethamine | 78 | $1,658 | $21 |
| Olopatadine | 17 | $1,592 | $94 |
| Brimonidine | 40 | $1,105 | $28 |
| Ciprofloxacin | 131 | $1,075 | $8 |
| Betaxolol | 15 | $716 | $48 |
| Dorzolamide | 37 | $586 | $16 |
| Dorzolamide-Timolol | 13 | $339 | $26 |
2017: 27 drugs
| Restasis | 505 | $396,512 | $785 |
| Lumigan | 485 | $196,129 | $404 |
| Travatan Z | 387 | $112,819 | $292 |
| Ilevro | 184 | $45,923 | $250 |
| Azopt | 131 | $45,313 | $346 |
| Durezol | 245 | $39,685 | $162 |
| Restasis Multidose | 69 | $39,326 | $570 |
| Combigan | 107 | $30,553 | $286 |
| Vigamox | 188 | $29,455 | $157 |
| Xiidra | 32 | $17,333 | $542 |
| Pazeo | 68 | $12,548 | $185 |
| Alphagan P | 47 | $11,059 | $235 |
| Simbrinza | 41 | $8,604 | $210 |
| Timolol Maleate | 265 | $8,176 | $31 |
| Latanoprost | 418 | $7,452 | $18 |
| Prednisolone Acetate | 130 | $5,911 | $45 |
| Prolensa | 25 | $5,828 | $233 |
| Pataday | 27 | $4,754 | $176 |
| Pilocarpine | 40 | $2,994 | $75 |
| Moxifloxacin | 26 | $2,069 | $80 |
| Brimonidine | 43 | $1,976 | $46 |
| Ketorolac Tromethamine | 35 | $1,000 | $29 |
| Ciprofloxacin | 124 | $837 | $7 |
| Dorzolamide | 43 | $768 | $18 |
| Dorzolamide-Timolol | 22 | $669 | $30 |
| Flurbiprofen | 51 | $357 | $7 |
| Neomycin-Polymyxin-Dexameth | 12 | $205 | $17 |
2016: 24 drugs
| Restasis | 321 | $177,836 | $554 |
| Lumigan | 411 | $133,164 | $324 |
| Travatan Z | 411 | $91,048 | $222 |
| Combigan | 105 | $22,544 | $215 |
| Durezol | 138 | $21,611 | $157 |
| Azopt | 76 | $20,148 | $265 |
| Vigamox | 89 | $13,458 | $151 |
| Ilevro | 54 | $12,527 | $232 |
| Pataday | 53 | $10,474 | $198 |
| Timolol Maleate | 280 | $8,185 | $29 |
| Prednisolone Acetate | 192 | $7,724 | $40 |
| Pazeo | 48 | $7,618 | $159 |
| Simbrinza | 48 | $7,415 | $154 |
| Alphagan P | 43 | $7,193 | $167 |
| Prolensa | 33 | $7,084 | $215 |
| Lotemax | 32 | $4,976 | $155 |
| Latanoprost | 285 | $3,977 | $14 |
| Ciprofloxacin | 259 | $2,146 | $8 |
| Brimonidine | 29 | $1,763 | $61 |
| Flurbiprofen | 257 | $1,654 | $6 |
| Olopatadine | 11 | $709 | $64 |
| Dorzolamide-Timolol | 19 | $407 | $21 |
| Neomycin-Polymyxin-Dexameth | 20 | $343 | $17 |
| Dorzolamide | 15 | $296 | $20 |
2015: 24 drugs
| Restasis | 250 | $125,616 | $502 |
| Lumigan | 302 | $72,389 | $240 |
| Travatan Z | 400 | $71,564 | $179 |
| Ilevro | 81 | $20,592 | $254 |
| Combigan | 113 | $17,786 | $157 |
| Vigamox | 116 | $16,115 | $139 |
| Lotemax | 95 | $14,770 | $155 |
| Azopt | 48 | $11,825 | $246 |
| Durezol | 75 | $11,466 | $153 |
| Prednisolone Acetate | 242 | $10,815 | $45 |
| Pataday | 45 | $8,740 | $194 |
| Prolensa | 39 | $8,328 | $214 |
| Timolol Maleate | 231 | $6,513 | $28 |
| Alphagan P | 21 | $4,447 | $212 |
| Patanol | 17 | $4,087 | $240 |
| Latanoprost | 297 | $3,996 | $13 |
| Brimonidine | 30 | $2,266 | $76 |
| Simbrinza | 18 | $2,155 | $120 |
| Ciprofloxacin | 201 | $1,867 | $9 |
| Flurbiprofen | 218 | $1,565 | $7 |
| Doxycycline Hyclate | 18 | $672 | $37 |
| Dorzolamide-Timolol | 24 | $519 | $22 |
| Dorzolamide | 11 | $324 | $29 |
| Neomycin-Polymyxin-Dexameth | 13 | $260 | $20 |
2014: 23 drugs
| Restasis | 331 | $135,945 | $411 |
| Lumigan | 285 | $49,882 | $175 |
| Travatan Z | 302 | $47,274 | $157 |
| Vigamox | 169 | $18,552 | $110 |
| Prednisolone Acetate | 289 | $15,238 | $53 |
| Combigan | 107 | $13,364 | $125 |
| Durezol | 101 | $12,708 | $126 |
| Prolensa | 51 | $9,999 | $196 |
| Pataday | 51 | $8,352 | $164 |
| Alphagan P | 55 | $8,165 | $148 |
| Lotemax | 50 | $7,341 | $147 |
| Azopt | 34 | $6,182 | $182 |
| Timolol Maleate | 214 | $5,658 | $26 |
| Brimonidine | 38 | $4,686 | $123 |
| Latanoprost | 247 | $4,151 | $17 |
| Nevanac | 24 | $3,975 | $166 |
| Ilevro | 18 | $3,108 | $173 |
| Flurbiprofen | 301 | $2,591 | $9 |
| Ciprofloxacin | 177 | $2,238 | $13 |
| Doxycycline Hyclate | 49 | $1,094 | $22 |
| Dorzolamide | 24 | $768 | $32 |
| Dorzolamide-Timolol | 19 | $661 | $35 |
| Neomycin-Polymyxin-Dexameth | 20 | $454 | $23 |
2013: 25 drugs
| Restasis | 471 | $166,209 | $353 |
| Lumigan | 291 | $40,708 | $140 |
| Durezol | 269 | $30,055 | $112 |
| Travatan Z | 217 | $28,583 | $132 |
| Vigamox | 255 | $26,677 | $105 |
| Bromday | 57 | $17,951 | $315 |
| Ilevro | 78 | $11,675 | $150 |
| Combigan | 87 | $10,528 | $121 |
| Pataday | 72 | $10,410 | $145 |
| Nevanac | 61 | $9,138 | $150 |
| Alphagan P | 56 | $7,592 | $136 |
| Prolensa | 38 | $6,747 | $178 |
| Azopt | 38 | $5,167 | $136 |
| Prednisolone Acetate | 269 | $4,799 | $18 |
| Doxycycline Hyclate | 177 | $4,655 | $26 |
| Timolol Maleate | 187 | $4,575 | $24 |
| Istalol | 22 | $3,244 | $147 |
| Betoptic S | 12 | $3,121 | $260 |
| Ciprofloxacin | 186 | $2,528 | $14 |
| Flurbiprofen | 277 | $2,434 | $9 |
| Latanoprost | 148 | $2,304 | $16 |
| Brimonidine | 22 | $1,573 | $71 |
| Dorzolamide | 21 | $909 | $43 |
| Dorzolamide-Timolol | 18 | $626 | $35 |
| Neomycin-Polymyxin-Dexameth | 27 | $499 | $18 |
Money from drug and device companies
$810 in 2025
| 2025 | 10 | 35 | None | $810 |
| 2024 | 9 | 40 | None | $929 |
| 2023 | 9 | 36 | None | $762 |
| 2022 | 8 | 26 | None | $753 |
| 2021 | 4 | 9 | None | $186 |
| 2020 | 5 | 14 | None | $233 |
| 2019 | 7 | 22 | None | $485 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Lumigan | $177 | 9 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $154 | 7 payments
|
| Bausch & Lomb Americas | Miebo | $106 | 5 payments
|
| Sight Sciences | Omni Surgical System | $80 | 2 payments
|
| Alcon Vision | Rocklatan | $79 | 3 payments
|
| Dompe US | Oxervate | $68 | 2 payments
|
See all 35 published payments
| Bausch & Lomb Americas | Meals · 2025-12-22 | Miebo | $17 |
| Abbvie | Meals · 2025-12-05 | Lumigan | $16 |
| Sight Sciences | Meals · 2025-12-04 | Omni Surgical System | $51 |
| Bausch & Lomb Americas | Meals · 2025-11-21 | Miebo | $18 |
| Abbvie | Meals · 2025-11-14 | Lumigan | $24 |
| Alcon Vision | Meals · 2025-11-11 | Rocklatan | $17 |
| Tarsus Pharmaceuticals | Meals · 2025-11-04 | Xdemvy | $7 |
| Oyster Point Pharma | Meals · 2025-10-28 | Tyrvaya | $16 |
| Thea Pharma | Meals · 2025-10-23 | Iyuzeh | $22 |
| Electromed | Meals · 2025-10-17 | Smartvest | $16 |
| Dompe US | Meals · 2025-10-08 | Oxervate | $36 |
| Tarsus Pharmaceuticals | Meals · 2025-10-07 | Xdemvy | $29 |
| Alcon Vision | Meals · 2025-09-29 | Rocklatan | $30 |
| Abbvie | Meals · 2025-09-04 | Lumigan | $29 |
| Oyster Point Pharma | Meals · 2025-08-26 | Tyrvaya | $21 |
| Bausch & Lomb Americas | Meals · 2025-08-20 | Miebo | $25 |
| Alcon Vision | Meals · 2025-07-10 | Rocklatan | $32 |
| Abbvie | Meals · 2025-06-27 | Lumigan | $11 |
| Tarsus Pharmaceuticals | Meals · 2025-06-13 | Xdemvy | $24 |
| Abbvie | Meals · 2025-06-06 | Lumigan | $12 |
| Electromed | Meals · 2025-05-27 | Smartvest | $20 |
| Tarsus Pharmaceuticals | Meals · 2025-05-20 | Xdemvy | $30 |
| Sight Sciences | Meals · 2025-05-06 | Omni Surgical System | $28 |
| Tarsus Pharmaceuticals | Meals · 2025-04-28 | Xdemvy | $14 |
| Abbvie | Meals · 2025-04-23 | Lumigan | $10 |
| Bausch & Lomb Americas | Meals · 2025-04-08 | Miebo | $23 |
| Abbvie | Meals · 2025-04-01 | Lumigan | $28 |
| Abbvie | Meals · 2025-03-04 | Lumigan | $20 |
| Bausch & Lomb Americas | Meals · 2025-03-04 | Miebo | $23 |
| Tarsus Pharmaceuticals | Meals · 2025-02-26 | Xdemvy | $23 |
| Stryker | Meals · 2025-02-05 | Na | $34 |
| Tarsus Pharmaceuticals | Meals · 2025-01-29 | Xdemvy | $27 |
| Dompe US | Meals · 2025-01-23 | Oxervate | $33 |
| Electromed | Meals · 2025-01-22 | Smartvest | $19 |
| Abbvie | Meals · 2025-01-09 | Lumigan | $27 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $929
| Abbvie | Lumigan | $241 | 10 payments
|
| Bausch & Lomb Americas | Miebo | $211 | 10 payments
|
| Alcon Vision | Hydrus Microstent | $131 | 7 payments
|
| Sight Sciences | Omni Surgical System | $117 | 4 payments
|
| Oyster Point Pharma | Tyrvaya | $115 | 4 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $50 | 2 payments
|
| Thea Pharma | Iyuzeh | $25 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $20 | 1 payment
|
| Dompe US | Oxervate | $19 | 1 payment
|
2023: $762
| Oyster Point Pharma | Tyrvaya | $183 | 10 payments
|
| Novartis Pharmaceuticals | Xiidra | $138 | 9 payments
|
| Glaukos | Istent Infinite Trabecular Micro-Bypass System Model Is3 | $110 | 2 payments
|
| Alcon Vision | Eysuvis | $92 | 4 payments
|
| Bausch & Lomb Americas | Miebo | $77 | 4 payments
|
| AbbVie | Lumigan | $61 | 2 payments
|
| Sight Sciences | Omni Surgical System | $52 | 2 payments
|
| Thea Pharma | Iyuzeh | $37 | 2 payments
|
| New World Medical | None | $12 | 1 payment
|
2022: $753
| Oyster Point Pharma | Tyrvaya | $136 | 3 payments
|
| Alcon Vision | Simbrinza | $124 | 7 payments
|
| Bausch & Lomb Americas | Vyzulta | $111 | 1 payment
|
| Abbvie | Lumigan | $104 | 4 payments
|
| Glaukos | Istent Inject W | $94 | 2 payments
|
| Sight Sciences | Omni(R) Surgical System (US) | $93 | 3 payments
|
| Kala Pharmaceuticals | Inveltys | $49 | 3 payments
|
| Novartis Pharmaceuticals | Xiidra | $42 | 3 payments
|
2021: $186
| Allergan | Durysta | $71 | 4 payments
|
| Aerie Pharmaceuticals | Rocklatan | $47 | 2 payments
|
| Integra LifeSciences | Amnioexcel | $46 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $23 | 1 payment
|
2020: $233
| Allergan | Durysta | $121 | 8 payments
|
| Sight Sciences | Omni | $49 | 3 payments
|
| Ivantis | Hydrus | $25 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $23 | 1 payment
|
| Bausch & Lomb a division of Bausch Health US | Prolensa | $15 | 1 payment
|
2019: $485
| Alcon Vision | Dailies | $143 | 2 payments
|
| Allergan | Restasis | $136 | 10 payments
|
| Sun Pharmaceutical Industries | Bromsite | $79 | 4 payments
|
| Sight Sciences | Omni | $43 | 2 payments
|
| Bausch & Lomb a division of Bausch Health US | Lotemax Sm | $41 | 2 payments
|
| Shire North American Group | Xiidra | $25 | 1 payment
|
| Aerie Pharmaceuticals | Rhopressa | $18 | 1 payment
|
Checkups this office reported
8 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 95.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Age-Related Macular Degeneration (AMD): Dilated Macular ExaminationAs Medicare defines this measure | 100% | 315 |
| Checked for fall riskOlder patients screened for fall risk | 98%That's most of the people this applied to. | 1,715 |
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 100%That's most of the people this applied to. | 711 |
| Glaucoma Intraocular Pressure ReductionAs Medicare defines this measure | 77% | 409 |
| Medications listed in the chartVisits where the current medication list was documented | 100%That's most of the people this applied to. | 3,011 |
| Primary Open-Angle Glaucoma (POAG): Optic Nerve EvaluationAs Medicare defines this measure | 100% | 880 |
| Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% OR Documentation of a Plan of CareAs Medicare defines this measure | 100% | 874 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 1,784 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
Professional record
- NPI
- 1033183934
- Licence
- CA A82768California A82768: Current · expires 2028-07-31
- Trained
- New York University School of Medicine, 1998 · 28 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 345 9th St, Suite 204, Oakland, CA, 94607
- NPI first listed
- 2006-02-15
- NPI last updated
- 2022-08-15
- NPI record certified
- 2022-08-15
This is when the NPI record was last certified, not a medical board exam.